Performance analysis of Aurinia Pharmaceuticals (AUPH)
Annual Return
Over the past 3 years, AUPH has had an average annual return of +17.32%, underperforming the benchmark SPY, which returned +22.77% annual.
Over the past 5 years, AUPH has had an average annual return of +3.76%, underperforming the benchmark SPY, which returned +14% annual.
Over the past 10 years, AUPH has had an average annual return of +17.77%, outperforming the benchmark SPY, which returned +15.53% annual.
Since Sep 3, 2014, AUPH has had an average annual return of +12.15%, underperforming the benchmark SPY, which returned +13.92% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -3.51% | +77.62% | -0.11% | +108.10% | -81.11% | +65.37% | -31.74% | +197.07% | +50.55% | +115.71% | -14.98% | -32.14% |
| 2014 | |||||||||||
| -9.00% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -8.90% | -2.48% | +4.59% | +3.81% | -0.36% | +0.39% | -3.51% | ||||||
| 2025 | -11.47% | +0% | +1.13% | +2.49% | -4.85% | +8.04% | +9.15% | +29.69% | -7.84% | +19.19% | +22.40% | -1.05% | +77.62% |
| 2024 | -16.13% | -24.14% | -12.41% | +1.60% | +6.48% | +5.35% | +2.98% | +15.82% | +7.64% | -1.64% | +22.88% | +1.35% | -0.11% |
| 2023 | +109.49% | +0.44% | +20.57% | +2.65% | -20.36% | +8.04% | +19.63% | -21.68% | -14.33% | -5.53% | +17.71% | +4.05% | +108.10% |
| 2022 | -27.15% | -26.17% | +0.65% | -16.88% | +9.62% | -10.90% | -18.61% | -10.02% | +2.17% | +8.11% | -36.90% | -15.79% | -81.11% |
| 2021 | +20.82% | -16.22% | -7.25% | +2.19% | +9.42% | -10.74% | +4.63% | +20.06% | +35.93% | +49.48% | -43.05% | +21.39% | +65.37% |
| 2020 | -9.67% | -4.37% | -17.09% | +18.81% | -7.95% | +2.39% | -13.05% | +4.95% | -0.67% | +6.45% | -3.06% | -9.01% | -31.74% |
| 2019 | -7.62% | +7.14% | -3.70% | -5.08% | +5.02% | +1.54% | -3.34% | -9.75% | -6.97% | -8.99% | +63.37% | +155.16% | +197.07% |
| 2018 | +17% | -1.70% | -0.38% | +1.16% | +11.05% | -3.43% | -3.91% | +3.14% | +19% | -18.07% | +11.40% | +12.54% | +50.55% |
| 2017 | +46.67% | +15.58% | +106.18% | -4.50% | -10.98% | -1.76% | +2.94% | +2.85% | -3.39% | -6.22% | -10.20% | -14.20% | +115.71% |
Drawdown analysis of Aurinia Pharmaceuticals (AUPH)
The maximum drawdown for the AUPH was -87.58%, occurring on Dec 27, 2022. This drawdown has not yet recovered.
The current AUPH drawdown is -53.48%.
Since Sep 3, 2014 AUPH has experienced the following drawdowns:
- 50% or more: 4 times
- 40% or more: 4 times
- 30% or more: 4 times
- 20% or more: 5 times
- 10% or more: 7 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -87.58% | Oct 29, 2021 | 291 | Dec 27, 2022 | Ongoing | Ongoing | Ongoing |
| -67.17% | Mar 23, 2015 | 208 | Jan 19, 2016 | 284 | Mar 6, 2017 | 492 |
| -63.19% | Mar 13, 2017 | 652 | Oct 14, 2019 | 37 | Dec 5, 2019 | 689 |
| -53.40% | Jan 2, 2020 | 340 | May 10, 2021 | 88 | Sep 14, 2021 | 428 |
| -27.75% | Sep 3, 2014 | 23 | Oct 14, 2014 | 32 | Nov 28, 2014 | 55 |
| -19.96% | Sep 27, 2021 | 7 | Oct 6, 2021 | 12 | Oct 22, 2021 | 19 |
| -17.28% | Nov 28, 2014 | 42 | Jan 30, 2015 | 18 | Feb 26, 2015 | 60 |
| -9.86% | Sep 14, 2021 | 2 | Sep 16, 2021 | 3 | Sep 21, 2021 | 5 |
| -8.49% | Mar 2, 2015 | 6 | Mar 10, 2015 | 5 | Mar 17, 2015 | 11 |
| -5.51% | Dec 26, 2019 | 2 | Dec 30, 2019 | 2 | Jan 2, 2020 | 4 |
| -3.03% | Dec 17, 2019 | 1 | Dec 18, 2019 | 3 | Dec 23, 2019 | 4 |
| -1.42% | Oct 26, 2021 | 1 | Oct 27, 2021 | 2 | Oct 29, 2021 | 3 |
| -1.15% | Sep 23, 2021 | 1 | Sep 24, 2021 | 1 | Sep 27, 2021 | 2 |
| -1.14% | Dec 11, 2019 | 1 | Dec 12, 2019 | 1 | Dec 13, 2019 | 2 |